Patents by Inventor Nathan P. Wiederhold

Nathan P. Wiederhold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11819503
    Abstract: The invention relates to the therapeutic use of olorofim, 2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2-oxoacetamide in the prevention and treatment of a fungal infection caused by a Coccidioides species.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: November 21, 2023
    Assignees: F2G Ltd
    Inventors: Derek Law, John H. Rex, Michael Birch, Nathan P. Wiederhold, Thomas F. Patterson
  • Publication number: 20220257578
    Abstract: Candida auris infection in a subject is treated with 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy}benzamidine (T-2307) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Applicant: Appili Therapeutics Inc.
    Inventors: Thomas F. PATTERSON, Nathan P. WIEDERHOLD, Laura K. NAJVAR
  • Publication number: 20110224232
    Abstract: A method of treating fungal infection by pulmonary administration of a solution of voriconazole and cyclodextrin is provided The fungal infection can be a pulmonary infection. The solution can be an inhalable aqueous formulation that can be administered via the mouth or nose. The cyclodextrin can be a water soluble cyclodextrin derivative such as sulfoalkyl ether cyclodextrin. The formulation can be administered via a spray device or nebulizer.
    Type: Application
    Filed: May 6, 2009
    Publication date: September 15, 2011
    Applicants: Board of Regents, The University of Texas System, CyDex Pharmaceuticals, Inc.
    Inventors: Robert O. Williams III, Rupert O. Zimmerer, Jason T. MxConville, Justin A. Tolman, Nathan P. Wiederhold, Jay I. Peters